| Name | Heritage Hall West |
|---|---|
| Location | 61 Cooper St, Agawam, Massachusetts |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 164 |
| Occupancy Rate | 54.51% |
| Medicare ID (CCN) | 225253 |
| Legal Business Name | 61 Cooper Street Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1053353060 |
| Organization Name | GENESIS HEALTH VENTURES OF MASSACHUSETTS, INC |
| Doing Business As | HERITAGE HALL WEST |
| Address | 61 Cooper St, Agawam, MA 01001 |
| Phone Number | 413-786-8000 |
News Archive
Synthon has successfully concluded multiple registration procedures for the cardiovascular drug Eplerenone. Synthon has obtained regulatory clearance for the product in nine European countries, for both 25 and 50 mg film coated tablets.
A £50 million research initiative, aimed at giving people '50 active years after 50' is being launched by the University of Leeds.
For a while now, some plastic surgeons have been using stem cells to treat aging, sun-damaged skin. But while they've been getting good results, it's been unclear exactly how these treatments - using adult stem cells harvested from the patient's own body - work to rejuvenate "photoaged" facial skin.
There is a high prevalence of nocturnal teeth grinding, or bruxism, in patients with obstructive sleep apnea (OSA), particularly in Caucasians. New research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that nearly 1 in 4 patients with OSA suffers from nighttime teeth grinding; this seems to be especially more prevalent in men and in Caucasians compared with other ethnic groups.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
› Verified 7 days ago
| NPI Number | 1952583775 |
| Organization Name | 61 COOPER STREET OPERATIONS LLC |
| Doing Business As | HERITAGE HALL WEST |
| Address | 61 Cooper St, Agawam, MA 01001 |
| Phone Number | 413-786-8000 |
News Archive
Synthon has successfully concluded multiple registration procedures for the cardiovascular drug Eplerenone. Synthon has obtained regulatory clearance for the product in nine European countries, for both 25 and 50 mg film coated tablets.
A £50 million research initiative, aimed at giving people '50 active years after 50' is being launched by the University of Leeds.
For a while now, some plastic surgeons have been using stem cells to treat aging, sun-damaged skin. But while they've been getting good results, it's been unclear exactly how these treatments - using adult stem cells harvested from the patient's own body - work to rejuvenate "photoaged" facial skin.
There is a high prevalence of nocturnal teeth grinding, or bruxism, in patients with obstructive sleep apnea (OSA), particularly in Caucasians. New research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that nearly 1 in 4 patients with OSA suffers from nighttime teeth grinding; this seems to be especially more prevalent in men and in Caucasians compared with other ethnic groups.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
› Verified 7 days ago
| NPI Number | 1992482723 |
| Organization Name | AGAWAM WEST REHAB AND NURSING LLC |
| Address | 61 Cooper St, Agawam, MA 01001 |
| Phone Number | 413-294-6800 |
News Archive
Synthon has successfully concluded multiple registration procedures for the cardiovascular drug Eplerenone. Synthon has obtained regulatory clearance for the product in nine European countries, for both 25 and 50 mg film coated tablets.
A £50 million research initiative, aimed at giving people '50 active years after 50' is being launched by the University of Leeds.
For a while now, some plastic surgeons have been using stem cells to treat aging, sun-damaged skin. But while they've been getting good results, it's been unclear exactly how these treatments - using adult stem cells harvested from the patient's own body - work to rejuvenate "photoaged" facial skin.
There is a high prevalence of nocturnal teeth grinding, or bruxism, in patients with obstructive sleep apnea (OSA), particularly in Caucasians. New research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that nearly 1 in 4 patients with OSA suffers from nighttime teeth grinding; this seems to be especially more prevalent in men and in Caucasians compared with other ethnic groups.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Synthon has successfully concluded multiple registration procedures for the cardiovascular drug Eplerenone. Synthon has obtained regulatory clearance for the product in nine European countries, for both 25 and 50 mg film coated tablets.
A £50 million research initiative, aimed at giving people '50 active years after 50' is being launched by the University of Leeds.
For a while now, some plastic surgeons have been using stem cells to treat aging, sun-damaged skin. But while they've been getting good results, it's been unclear exactly how these treatments - using adult stem cells harvested from the patient's own body - work to rejuvenate "photoaged" facial skin.
There is a high prevalence of nocturnal teeth grinding, or bruxism, in patients with obstructive sleep apnea (OSA), particularly in Caucasians. New research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that nearly 1 in 4 patients with OSA suffers from nighttime teeth grinding; this seems to be especially more prevalent in men and in Caucasians compared with other ethnic groups.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 2 |
| Total Amount of Fines in Dollars | $47256 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 2 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.97 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 7.67 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 65.85 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.62 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.97 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.38 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.85 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 78.09 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.16 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 36.47 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.75 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 34.53 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 10.78 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 12.59 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 88.89 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 55.85 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 69.1 | 82.93 |
News Archive
Synthon has successfully concluded multiple registration procedures for the cardiovascular drug Eplerenone. Synthon has obtained regulatory clearance for the product in nine European countries, for both 25 and 50 mg film coated tablets.
A £50 million research initiative, aimed at giving people '50 active years after 50' is being launched by the University of Leeds.
For a while now, some plastic surgeons have been using stem cells to treat aging, sun-damaged skin. But while they've been getting good results, it's been unclear exactly how these treatments - using adult stem cells harvested from the patient's own body - work to rejuvenate "photoaged" facial skin.
There is a high prevalence of nocturnal teeth grinding, or bruxism, in patients with obstructive sleep apnea (OSA), particularly in Caucasians. New research presented at CHEST 2009, the 75th annual international scientific assembly of the American College of Chest Physicians (ACCP), found that nearly 1 in 4 patients with OSA suffers from nighttime teeth grinding; this seems to be especially more prevalent in men and in Caucasians compared with other ethnic groups.
Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4>th EAACI Congress in London on June 7th. The results will be presented by the study's principal investigator Prof. Eric Bateman.
› Verified 7 days ago
Memory Support Of Heritage Hall Location: 464 Main Street, Agawam, Massachusetts 01001 Phone: (413) 786-8000 | |